Veliparib and topotecan for patients with platinum-resistant or partially platinum-sensitive relapse of epithelial ovarian cancer with BRCA negative or unknown BRCA status

Mette Hjortkjær*, Hanne Kanstrup, Anders Jakobsen, Karina Dahl Steffensen

*Corresponding author for this work

Research output: Contribution to journalJournal articleResearchpeer-review

14 Citations (Scopus)
Original languageEnglish
JournalCancer Treatment and Research Communications
Volume14
Pages (from-to)7-12
Number of pages6
ISSN2468-2942
DOIs
Publication statusPublished - 2018

Cite this